JP2017501978A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501978A5
JP2017501978A5 JP2016533153A JP2016533153A JP2017501978A5 JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5 JP 2016533153 A JP2016533153 A JP 2016533153A JP 2016533153 A JP2016533153 A JP 2016533153A JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
optionally substituted
methyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533153A
Other languages
English (en)
Japanese (ja)
Other versions
JP6496728B2 (ja
JP2017501978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066608 external-priority patent/WO2015077451A1/en
Publication of JP2017501978A publication Critical patent/JP2017501978A/ja
Publication of JP2017501978A5 publication Critical patent/JP2017501978A5/ja
Application granted granted Critical
Publication of JP6496728B2 publication Critical patent/JP6496728B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533153A 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体 Expired - Fee Related JP6496728B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361907320P 2013-11-21 2013-11-21
US61/907,320 2013-11-21
PCT/US2014/066608 WO2015077451A1 (en) 2013-11-21 2014-11-20 Phenylcarbamate derivatives as formyl peptide receptor modulators

Publications (3)

Publication Number Publication Date
JP2017501978A JP2017501978A (ja) 2017-01-19
JP2017501978A5 true JP2017501978A5 (https=) 2017-11-24
JP6496728B2 JP6496728B2 (ja) 2019-04-03

Family

ID=52101595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533153A Expired - Fee Related JP6496728B2 (ja) 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体

Country Status (10)

Country Link
US (1) US9926264B2 (https=)
EP (1) EP3071548B1 (https=)
JP (1) JP6496728B2 (https=)
KR (1) KR102310615B1 (https=)
CN (1) CN105705484B (https=)
AU (1) AU2014352922B2 (https=)
BR (1) BR112016011417A8 (https=)
CA (1) CA2930084A1 (https=)
RU (1) RU2703725C1 (https=)
WO (1) WO2015077451A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012329098B2 (en) 2011-10-26 2017-08-03 Allergan, Inc. Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
KR102223384B1 (ko) 2013-03-06 2021-03-05 알러간, 인코포레이티드 피부 질환 치료용 포르밀 펩티드 수용체 2의 항진제의 용도
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
WO2015179707A1 (en) 2014-05-21 2015-11-26 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163221A (ja) * 1991-12-17 1993-06-29 Fujirebio Inc オキシ酸誘導体
CN1235875C (zh) * 1999-08-27 2006-01-11 西托维亚公司 取代的α-羟基酸天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
PL2432760T3 (pl) * 2009-05-18 2013-12-31 Actelion Pharmaceuticals Ltd Pochodne zmostkowanego spiro[2.4]heptanu jako agoniści receptora alx i/lub fprl2
CA2819457A1 (en) 2010-12-03 2012-06-07 Allergan, Inc. Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
EP2673263A1 (en) 2011-02-11 2013-12-18 Allergan, Inc. Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
AU2012329098B2 (en) 2011-10-26 2017-08-03 Allergan, Inc. Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US8541577B2 (en) 2011-11-10 2013-09-24 Allergan, Inc. Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
US8492556B2 (en) 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
EP2814815A1 (en) 2012-02-16 2014-12-24 Allergan, Inc. Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
ES2711363T3 (es) 2012-04-16 2019-05-03 Allergan Inc Derivados de (2-ureidoacetamido)alquilo como moduladores del receptor 2 de péptidos formilados
RU2696581C2 (ru) 2013-07-16 2019-08-05 Аллерган, Инк. Производные n-мочевинозамещенных аминокислот как модуляторы формил-пептидного рецептора
US9920013B2 (en) 2014-01-29 2018-03-20 Allergan, Inc. 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
US9604934B2 (en) 2014-01-29 2017-03-28 Allergan, Inc. Urea hydantoin derivatives as formyl peptide modulators
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
WO2015179707A1 (en) 2014-05-21 2015-11-26 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators

Similar Documents

Publication Publication Date Title
JP2017501978A5 (https=)
RU2017129434A (ru) Амидные производные n-карбамид-замещенных аминокислот как модуляторы формилпептидного рецептора-1 (fprl-1)
JP2016529235A5 (https=)
JP2015520130A5 (https=)
RU2016119347A (ru) Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора
ES2232114T3 (es) Derivados de cicloalqueno, procedimiento para su produccion, y uso.
JP2014525426A5 (https=)
NZ610230A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
JP2019505541A5 (https=)
RU2013132650A (ru) Серные производные в качестве модуляторов хемокиновых рецепторов
RU2013150332A (ru) Замещенные бициклические метиламинные производные как модуляторы рецепторов сфингозин-1-фосфата
JP2014502979A5 (https=)
JP2016512193A5 (https=)
EA201591775A1 (ru) Замещенные ароматические соединения и связанный с ними способ лечения фиброза
RU2009136911A (ru) Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств
JP2014533274A5 (https=)
JP2015520130A (ja) ホルミルペプチド受容体2調節物質としての(2−ウレイドアセトアミド)アルキル誘導体
JP2012526082A5 (https=)
JP2017520528A5 (https=)
JP2017537937A5 (https=)
HRP20170045T1 (hr) Difluorlaktamski spojevi kao selektivni agonisti ep4 receptora za uporabu za liječenje bolesti i stanja posredovanih s ep4 receptorom
RU2005137155A (ru) Производные 9-азабицикло [3.3.1] нон-6-ена с гетероатомом на позиции 3 как ингибиторы ренина
MX2024008172A (es) Procedimiento para la preparación del ácido (5s)-{[2-(4-carboxifenil)etil][2- (2-{[3-cloro-4'-(trifluorometil)bifenil-4-il]metoxi}fenil)etil]amino}-5,6,7,8- tetrahidroquinolina-2-carboxílico y sus formas cristalinas para su uso como compuesto farmacéuticamente activo
JP2008517897A5 (https=)
RU2013130022A (ru) Новые бензиловые производные азетидина в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)